1B41 | A:5-543 | HUMAN ACETYLCHOLINESTERASE COMPLEXED WITH FASCICULIN-II, GLYCOSYLATED PROTEIN |
1F6W | A:1-533 | STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN BILE SALT ACTIVATED LIPASE |
1F8U | A:5-543 | CRYSTAL STRUCTURE OF MUTANT E202Q OF HUMAN ACETYLCHOLINESTERASE COMPLEXED WITH GREEN MAMBA VENOM PEPTIDE FASCICULIN-II |
1FJ2 | A:-5-224; B:-5-224 | CRYSTAL STRUCTURE OF THE HUMAN ACYL PROTEIN THIOESTERASE 1 AT 1.5 A RESOLUTION |
1HLG | A:9-379; B:9-379 | CRYSTAL STRUCTURE OF HUMAN GASTRIC LIPASE |
1IMJ | A:2-209 | CRYSTAL STRUCTURE OF THE HUMAN CCG1/TAFII250-INTERACTING FACTOR B (CIB) |
1IVY | B:1-452; A:1-452 | PHYSIOLOGICAL DIMER HPP PRECURSOR |
1J2E | A:509-766; B:509-766 | CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV |
1JMY | A:1-522 | TRUNCATED RECOMBINANT HUMAN BILE SALT STIMULATED LIPASE |
1MX1 | B:2022-2553; C:3022-3553; D:4022-4553; E:5022-5553; F:6022-6553; A:1021-1553 | CRYSTAL STRUCTURE OF HUMAN LIVER CARBOXYLESTERASE IN COMPLEX WITH TACRINE |
1MX5 | B:2022-2553; C:3022-3553; E:5022-5553; F:6022-6553; A:1021-1553; D:4021-4553 | CRYSTAL STRUCTURE OF HUMAN LIVER CARBOXYLESTERASE IN COMPLEXED WITH HOMATROPINE, A COCAINE ANALOGUE |
1MX9 | C:3022-3553; E:5022-5553; F:6022-6553; H:2022-2553; I:3022-3553; K:5022-5553; L:6022-6553; A:1021-1553; B:2021-2553; G:1021-1553; J:4021-4553; D:4021-4554 | CRYSTAL STRUCTURE OF HUMAN LIVER CARBOXYLESTERASE IN COMPLEXED WITH NALOXONE METHIODIDE, A HEROIN ANALOGUE |
1N1M | B:509-766; A:39-51,A:506-764 | HUMAN DIPEPTIDYL PEPTIDASE IV/CD26 IN COMPLEX WITH AN INHIBITOR |
1N8S | A:1-337 | STRUCTURE OF THE PANCREATIC LIPASE-COLIPASE COMPLEX |
1NU6 | A:509-766; B:509-766 | CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV (DPP-IV) |
1NU8 | A:509-766; B:509-766 | CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV (DPP-IV) IN COMPLEX WITH DIPROTIN A (IPI) |
1P0I | A:4-529 | CRYSTAL STRUCTURE OF HUMAN BUTYRYL CHOLINESTERASE |
1P0M | A:4-529 | CRYSTAL STRUCTURE OF HUMAN BUTYRYL CHOLINESTERASE IN COMPLEX WITH A CHOLINE MOLECULE |
1P0P | A:4-529 | CRYSTAL STRUCTURE OF SOMAN-AGED HUMAN BUTYRYL CHOLINESTERASE IN COMPLEX WITH THE SUBSTRATE ANALOG BUTYRYLTHIOCHOLINE |
1P0Q | A:4-529 | CRYSTAL STRUCTURE OF SOMAN-AGED HUMAN BUTYRYL CHOLINESTERASE |
1PFQ | A:509-766; B:509-766 | CRYSTAL STRUCTURE OF HUMAN APO DIPEPTIDYL PEPTIDASE IV / CD26 |
1PJA | A:35-302 | THE CRYSTAL STRUCTURE OF PALMITOYL PROTEIN THIOESTERASE-2 REVEALS THE BASIS FOR DIVERGENT SUBSTRATE SPECIFICITIES OF THE TWO LYSOSOMAL THIOESTERASES (PPT1 AND PPT2) |
1R9M | A:509-766; B:509-766; C:509-766; D:509-766 | CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV AT 2.1 ANG. RESOLUTION. |
1R9N | A:509-766; B:509-766; C:509-766; D:509-766 | CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV IN COMPLEX WITH A DECAPEPTIDE (TNPY) AT 2.3 ANG. RESOLUTION |
1RWQ | A:39-51,A:506-766; B:39-51,B:506-766 | HUMAN DIPEPTIDYL PEPTIDASE IV IN COMPLEX WITH 5-AMINOMETHYL-6-(2,4-DICHLORO-PHENYL)-2-(3,5-DIMETHOXY-PHENYL)-PYRIMIDIN-4-YLAMINE |
1S8O | A:237-548 | HUMAN SOLUBLE EPOXIDE HYDROLASE |
1TK3 | B:509-766; A:509-764 | CRYSTAL STRUCTURE OF HUMAN APO DIPEPTIDYL PEPTIDASE IV/CD26 |
1TKR | B:509-766; A:509-764 | HUMAN DIPEPTIDYL PEPTIDASE IV/CD26 INHIBITED WITH DIISOPROPYL FLUOROPHOSPHATE |
1U8E | B:509-766; A:509-764 | HUMAN DIPEPTIDYL PEPTIDASE IV/CD26 MUTANT Y547F |
1VJ5 | A:235-547 | HUMAN SOLUBLE EPOXIDE HYDROLASE- N-CYCLOHEXYL-N'-(4-IODOPHENYL)UREA COMPLEX |
1W1I | A:509-766; B:509-766; C:509-766; D:509-766 | CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV (DPPIV OR CD26) IN COMPLEX WITH ADENOSINE DEAMINASE |
1WCY | A:509-766; B:509-766 | CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV (DPPIV) COMPLEX WITH DIPROTIN A |
1X70 | A:39-51,A:506-766; B:39-51,B:506-766 | HUMAN DIPEPTIDYL PEPTIDASE IV IN COMPLEX WITH A BETA AMINO ACID INHIBITOR |
1XFD | A:591-849; B:591-849; C:591-849; D:591-849 | STRUCTURE OF A HUMAN A-TYPE POTASSIUM CHANNEL ACCELERATING FACTOR DPPX, A MEMBER OF THE DIPEPTIDYL AMINOPEPTIDASE FAMILY |
1XKT | A:2217-2342,A:2433-2502; B:2217-2342,B:2433-2502 | HUMAN FATTY ACID SYNTHASE: STRUCTURE AND SUBSTRATE SELECTIVITY OF THE THIOESTERASE DOMAIN |
1XLU | A:4-529 | X-RAY STRUCTURE OF DI-ISOPROPYL-PHOSPHORO-FLUORIDATE (DFP) INHIBITED BUTYRYLCHOLINESTERASE AFTER AGING |
1XLV | A:4-529 | ETHYLPHOSPHORYLATED BUTYRYLCHOLINESTERASE (AGED) OBTAINED BY REACTION WITH ECHOTHIOPHATE |
1XLW | A:4-529 | DIETHYLPHOSPHORYLATED BUTYRYLCHOLINESTERASE (NONAGED) OBTAINED BY REACTION WITH ECHOTHIOPHATE |
1YA4 | A:22-553; B:21-553; C:21-553 | CRYSTAL STRUCTURE OF HUMAN LIVER CARBOXYLESTERASE 1 IN COMPLEX WITH TAMOXIFEN |
1YA8 | A:21-553; B:21-553; C:21-553 | CRYSTAL STRUCTURE OF HUMAN LIVER CARBOXYLESTERASE IN COMPLEX WITH CLEAVAGE PRODUCTS OF MEVASTATIN |
1YAH | A:21-553; B:21-553; C:21-553 | CRYSTAL STRUCTURE OF HUMAN LIVER CARBOXYLESTERASE COMPLEXED TO ETYL ACETATE; A FATTY ACID ETHYL ESTER ANALOGUE |
1YAJ | A:21-553; B:21-553; C:21-553; D:21-553; E:21-553; F:21-553; G:21-553; H:21-553; I:21-553; J:21-553; K:21-553; L:21-553 | CRYSTAL STRUCTURE OF HUMAN LIVER CARBOXYLESTERASE IN COMPLEX WITH BENZIL |
1Z68 | A:503-757; B:503-757 | CRYSTAL STRUCTURE OF HUMAN FIBROBLAST ACTIVATION PROTEIN ALPHA |
1ZD2 | P:235-547 | HUMAN SOLUBLE EPOXIDE HYDROLASE 4-(3-CYCLOHEXYLURIEDO)-ETHANOIC ACID COMPLEX |
1ZD3 | A:235-547 | HUMAN SOLUBLE EPOXIDE HYDROLASE 4-(3-CYCLOHEXYLURIEDO)-BUTYRIC ACID COMPLEX |
1ZD4 | A:235-547 | HUMAN SOLUBLE EPOXIDE HYDROLASE 4-(3-CYCLOHEXYLURIEDO)-HEXANOIC ACID COMPLEX |
1ZD5 | A:235-547 | HUMAN SOLUBLE EPOXIDE HYDROLASE 4-(3-CYCLOHEXYLURIEDO)-HEPTANOIC ACID COMPLEX |
2AJL | J:39-51,J:506-766; I:41-51,I:506-766 | X-RAY STRUCTURE OF NOVEL BIARYL-BASED DIPEPTIDYL PEPTIDASE IV INHIBITOR |
2BGN | A:39-51,A:506-766; B:39-51,B:506-766; C:39-51,C:506-766; D:39-51,D:506-766 | HIV-1 TAT PROTEIN DERIVED N-TERMINAL NONAPEPTIDE TRP2-TAT (1-9) BOUND TO THE ACTIVE SITE OF DIPEPTIDYL PEPTIDASE IV (CD26) |
2BGR | A:509-766; B:509-766 | CRYSTAL STRUCTURE OF HIV-1 TAT DERIVED NONAPEPTIDES TAT(1-9) BOUND TO THE ACTIVE SITE OF DIPEPTIDYL PEPTIDASE IV (CD26) |
2BUB | A:39-51,A:506-766; B:39-51,B:506-766 | CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV (CD26) IN COMPLEX WITH A REVERSED AMIDE INHIBITOR |
2DQY | A:1021-1553; B:2021-2553; C:3021-3553 | CRYSTAL STRUCTURE OF HUMAN CARBOXYLESTERASE IN COMPLEX WITH CHOLATE AND PALMITATE |
2DQZ | A:1021-1553; B:2021-2553; C:3021-3553 | CRYSTAL STRUCTURE OF HUMAN CARBOXYLESTERASE IN COMPLEX WITH HOMATROPINE, COENZYME A, AND PALMITATE |
2DR0 | A:1021-1553; B:2021-2553; C:3021-3553 | CRYSTAL STRUCTURE OF HUMAN CARBOXYLESTERASE IN COMPLEX WITH TAUROCHOLATE |
2FJP | A:39-51,A:506-766; B:39-51,B:506-766 | HUMAN DIPEPTIDYL PEPTIDASE IV/CD26 IN COMPLEX WITH AN INHIBITOR |
2G5P | A:39-51,A:506-764; B:39-51,B:506-764 | CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV (DPPIV) COMPLEXED WITH CYANOPYRROLIDINE (C5-PRO-PRO) INHIBITOR 21AC |
2G5T | A:39-51,A:506-764; B:39-51,B:506-764 | CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV (DPPIV) COMPLEXED WITH CYANOPYRROLIDINE (C5-PRO-PRO) INHIBITOR 21AG |
2G63 | A:39-51,A:506-764; B:39-51,B:506-764; C:39-51,C:506-764; D:39-51,D:506-764 | CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV (DPPIV) COMPLEXED WITH CYANOPYRROLIDINE (C5-PRO-PRO) INHIBITOR 24B |
2H7C | B:2022-2553; C:3022-3553; E:5022-5553; F:6022-6553; A:1021-1553; D:4021-4553 | CRYSTAL STRUCTURE OF HUMAN CARBOXYLESTERASE IN COMPLEX WITH COENZYME A |
2HHA | A:39-51,A:506-766; B:39-51,B:506-766 | THE STRUCTURE OF DPP4 IN COMPLEX WITH AN OXADIAZOLE INHIBITOR |
2HRQ | B:2022-2553; C:3022-3553; E:5022-5553; F:6022-6553; A:1021-1553; D:4021-4553 | CRYSTAL STRUCTURE OF HUMAN LIVER CARBOXYLESTERASE 1 (HCE1) IN COVALENT COMPLEX WITH THE NERVE AGENT SOMAN (GD) |
2HRR | B:2022-2553; C:3022-3553; A:1021-1553 | CRYSTAL STRUCTURE OF HUMAN LIVER CARBOXYLESTERASE 1 (HCE1) IN COVALENT COMPLEX WITH THE NERVE AGENT TABUN (GA) |
2I03 | A:39-51,A:506-764; B:39-51,B:506-764; C:39-51,C:506-764; D:39-51,D:506-764 | CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE 4 (DPP IV) WITH POTENT ALKYNYL CYANOPYRROLIDINE (ABT-279) |
2I78 | A:39-51,A:506-764; B:39-51,B:506-764; C:39-51,C:506-764; D:39-51,D:506-764 | CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV (DPP IV) COMPLEXED WITH ABT-341, A CYCLOHEXENE-CONSTRAINED PHENETHYLAMINE INHIBITOR |
2IIT | A:39-51,A:506-766; B:39-51,B:506-766 | HUMAN DIPEPTIDYL PEPTIDASE 4 IN COMPLEX WITH A DIAZEPAN-2-ONE INHIBITOR |
2IIV | A:39-51,A:506-766; B:39-51,B:506-766 | HUMAN DIPEPTIDYL PEPTIDASE 4 IN COMPLEX WITH A DIAZEPAN-2-ONE INHIBITOR |
2J4C | A:4-529 | STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH 10MM HGCL2 |
2JID | A:509-766; B:509-766 | HUMAN DIPEPTIDYL PEPTIDASE IV IN COMPLEX WITH 1-(3,4-DIMETHOXY-PHENYL)-3-M-TOLYL-PIPERIDINE-4-YLAMINE |
2OAG | A:39-51,A:506-764; B:39-51,B:506-764; C:39-51,C:506-764; D:39-51,D:506-764 | CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV (DPPIV) WITH PYRROLIDINE-CONSTRAINED PHENETHYLAMINE 29G |
2OGZ | B:39-51,B:506-766; A:39-51,A:506-764 | CRYSTAL STRUCTURE OF DPP-IV COMPLEXED WITH LILLY ARYL KETONE INHIBITOR |
2OLE | B:39-51,B:506-766; A:39-51,A:506-764 | CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV (DPPIV) COMPLEX WITH CYCLIC HYDRAZINE DERIVATIVES |
2ONC | A:509-766; B:509-766; C:509-766; D:509-766 | CRYSTAL STRUCTURE OF HUMAN DPP-4 |
2OPH | A:39-51,A:506-766; B:39-51,B:506-766 | HUMAN DIPEPTIDYL PEPTIDASE IV IN COMPLEX WITH AN ALPHA AMINO ACID INHIBITOR |
2OQI | A:39-51,A:506-764; B:39-51,B:506-764; C:39-51,C:506-764; D:39-51,D:506-764 | HUMAN DIPEPTIDYL PEPTIDASE IV (DPP4) WITH PIPERIDINONE-CONSTRAINED PHENETHYLAMINE |
2OQV | A:39-51,A:506-764; B:39-51,B:506-764 | HUMAN DIPEPTIDYL PEPTIDASE IV (DPP4) WITH PIPERIDINE-CONSTRAINED PHENETHYLAMINE |
2P8S | A:39-51,A:506-766; B:39-51,B:506-766 | HUMAN DIPEPTIDYL PEPTIDASE IV/CD26 IN COMPLEX WITH A CYCLOHEXALAMINE INHIBITOR |
2PM8 | A:4-534; B:4-534 | CRYSTAL STRUCTURE OF RECOMBINANT FULL LENGTH HUMAN BUTYRYLCHOLINESTERASE |
2PX6 | B:2221-2343,B:2433-2507; A:2221-2342,A:2433-2501 | CRYSTAL STRUCTURE OF THE THIOESTERASE DOMAIN OF HUMAN FATTY ACID SYNTHASE INHIBITED BY ORLISTAT |
2QJR | A:509-766; B:509-766 | DIPEPDYL PEPTIDASE IV IN COMPLEX WITH INHIBITOR PZF |
2QKY | A:39-51,A:506-766; B:39-51,B:506-766; C:39-51,C:506-766; D:39-51,D:506-766 | COMPLEX STRUCTURE OF DIPEPTIDYL PEPTIDASE IV AND A OXADIAZOLYL KETONE |
2QOE | A:39-51,A:506-766; B:39-51,B:506-766 | HUMAN DIPEPTIDYL PEPTIDASE IV IN COMPLEX WITH A TRIAZOLOPIPERAZINE-BASED BETA AMINO ACID INHIBITOR |
2QS9 | A:3-194; B:3-182 | CRYSTAL STRUCTURE OF THE HUMAN RETINOBLASTOMA-BINDING PROTEIN 9 (RBBP-9). NESG TARGET HR2978 |
2QT9 | A:39-51,A:506-766; B:39-51,B:506-766 | HUMAN DIPEPTIDYL PEPTIDASE IV/CD26 IN COMPLEX WITH A 4-ARYL CYCLOHEXYLALANINE INHIBITOR |
2QTB | A:39-51,A:506-766; B:39-51,B:506-766 | HUMAN DIPEPTIDYL PEPTIDASE IV/CD26 IN COMPLEX WITH A 4-ARYL CYCLOHEXYLALANINE INHIBITOR |
2RGU | A:509-766; B:509-766 | CRYSTAL STRUCTURE OF COMPLEX OF HUMAN DPP4 AND INHIBITOR |
2RIP | A:38-51,A:506-766 | STRUCTURE OF DPPIV IN COMPLEX WITH AN INHIBITOR |
2WID | A:3-529 | NONAGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA1 |
2WIF | A:3-529 | AGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA1 |
2WIG | A:3-529 | NONAGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA4 |
2WIJ | A:3-529 | NONAGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA5 |
2WIK | A:3-529 | NONAGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA6 |
2WIL | B:4-529; A:2-529 | AGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA5 |
2WQZ | B:41-599; A:36-598 | CRYSTAL STRUCTURE OF SYNAPTIC PROTEIN NEUROLIGIN-4 IN COMPLEX WITH NEUREXIN-BETA 1: ALTERNATIVE REFINEMENT |
2WSL | A:3-529 | AGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA4 |
3BE8 | B:-2-597; A:-8-597 | CRYSTAL STRUCTURE OF THE SYNAPTIC PROTEIN NEUROLIGIN 4 |
3BJM | A:39-51,A:506-766; B:39-51,B:506-766 | CRYSTAL STRUCTURE OF HUMAN DPP-IV IN COMPLEX WITH (1S,3S, 5S)-2-[(2S)-2-AMINO-2-(3-HYDROXYTRICYCLO[3.3.1.13,7]DEC-1- YL)ACETYL]-2-AZABICYCLO[3.1.0]HEXANE-3-CARBONITRILE (CAS), (1S,3S,5S)-2-((2S)-2-AMINO-2-(3-HYDROXYADAMANTAN-1- YL)ACETYL)-2-AZABICYCLO[3.1.0]HEXANE-3-CARBONITRILE (IUPAC), OR BMS-477118 |
3C43 | A:39-51,A:506-766; B:39-51,B:506-766 | HUMAN DIPEPTIDYL PEPTIDASE IV/CD26 IN COMPLEX WITH A FLOUROOLEFIN INHIBITOR |
3C45 | A:39-51,A:506-766; B:39-51,B:506-766 | HUMAN DIPEPTIDYL PEPTIDASE IV/CD26 IN COMPLEX WITH A FLUOROOLEFIN INHIBITOR |
3CCB | A:509-766; B:509-766; C:509-766; D:509-766 | CRYSTAL STRUCTURE OF HUMAN DPP4 IN COMPLEX WITH A BENZIMIDAZOLE DERIVATIVE |
3CCC | A:509-766; B:509-766; C:509-766; D:509-766 | CRYSTAL STRUCTURE OF HUMAN DPP4 IN COMPLEX WITH A BENZIMIDAZOLE DERIVATIVE |
3D4L | A:39-51,A:506-766; B:39-51,B:506-766 | HUMAN DIPEPTIDYL PEPTIDASE IV/CD26 IN COMPLEX WITH A NOVEL INHIBITOR |
3DDU | A:2-73,A:427-710 | PROLYL OLIGOPEPTIDASE WITH GSK552 |
3DJY | A:3-529 | NONAGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN |
3DKK | A:3-529 | AGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN |
3EIO | B:39-51,B:506-766; A:39-51,A:506-764 | CRYSTAL STRUCTURE ANALYSIS OF DPPIV INHIBITOR |
3FCX | B:3-281; A:1-282 | CRYSTAL STRUCTURE OF HUMAN ESTERASE D |
3G0B | A:509-766; B:509-766; C:509-766; D:509-766 | CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV IN COMPLEX WITH TAK-322 |
3G0C | A:509-766; B:509-766; C:509-766; D:509-766 | CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV IN COMPLEX WITH A PYRIMIDINEDIONE INHIBITOR 1 |
3G0D | A:509-766; B:509-766; C:509-766; D:509-766 | CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV IN COMPLEX WITH A PYRIMIDINEDIONE INHIBITOR 2 |
3G0G | A:509-766; B:509-766; C:509-766; D:509-766 | CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV IN COMPLEX WITH A PYRIMIDINONE INHIBITOR 3 |
3GRO | A:30-306; B:31-305 | HUMAN PALMITOYL-PROTEIN THIOESTERASE 1 |
3H0C | A:39-51,A:506-766; B:39-51,B:506-766 | CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV (CD26) IN COMPLEX WITH A REVERSED AMIDE INHIBITOR |
3HAB | A:39-51,A:506-766; B:39-51,B:506-766 | THE STRUCTURE OF DPP4 IN COMPLEX WITH PIPERIDINE FUSED BENZIMIDAZOLE 25 |
3HAC | A:39-51,A:506-766; B:39-51,B:506-766 | THE STRUCTURE OF DPP-4 IN COMPLEX WITH PIPERIDINE FUSED IMIDAZOPYRIDINE 34 |
3I1Y | A:237-548 | CRYSTAL STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE |
3I28 | A:237-548 | CRYSTAL STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE |
3K9B | A:1024-1549 | CRYSTAL STRUCTURE OF HUMAN LIVER CARBOXYLESTERASE 1 (HCE1) IN COVALENT COMPLEX WITH THE NERVE AGENT CYCLOSARIN (GF) |
3KOO | A:237-548 | CRYSTAL STRUCTURE OF SOLUBLE EPOXIDE HYDROLASE |